Andy Morley
Private Equity Investor chez o2h Ltd
Profil
Andy Morley is currently employed as a Principal at o2h Ltd and as a CSO at Opal Therapeutics Ltd.
He graduated from the University of Salford in 1990 with a graduate degree and also attended Nagoya University where he earned a graduate degree.
Postes actifs de Andy Morley
| Sociétés | Poste | Début |
|---|---|---|
o2h Ltd
 o2h Ltd Investment ManagersFinance O2h Ltd (O2h) is a venture capital firm. The firm is founded by Sunil and Prashant Shah. It is headquartered in United Kingdom. | Private Equity Investor | 01/01/2013 |
Opal Therapeutics Ltd.
 Opal Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opal Oncology Ltd. operates as a pharmaceutical company. It develops drugs for cancer. The company was founded in 2012 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | 01/06/2012 |
Formation de Andy Morley
| Nagoya University | Graduate Degree |
| University of Salford | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
o2h Ltd
o2h Ltd Investment ManagersFinance O2h Ltd (O2h) is a venture capital firm. The firm is founded by Sunil and Prashant Shah. It is headquartered in United Kingdom. | Finance |
Opal Therapeutics Ltd.
Opal Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opal Oncology Ltd. operates as a pharmaceutical company. It develops drugs for cancer. The company was founded in 2012 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
